Search Results

A Prospective, Open-Label, Single-Arm, Phase II Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With Diffuse Large B-Cell Lymphoma (ACRUE) Brief Summary: The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large B-cell lymphoma (DLBCL), who are otherwise…

A person holds a lit cigarette between their fingers while seated Cancer is a formidable adversary that affects millions of lives worldwide. While there’s no way to eliminate the risk of cancer altogether, understanding the factors that contribute to it can help you make informed choices and reduce your risk. In honor of February’s National…